A comprehensive view of Perrigo PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Perrigo's Opill, the first daily birth control pill available without a prescription in the US, begins shipping to retailers nationwide and online pre-orders open; manufacturer's suggested retail price at set at US$19.99 to US$49.99
Published:
March 04, 2024
by PR Newswire
|
Opill, the first OTC birth control pill approved in the US, is set to be launched by Perrigo in Q1 2024; many states are enacting laws that enable pharmacists to prescribe birth control without a doctor's prescription, with 29 states already allowing this
Published:
January 15, 2024
by Philadelphia Tribune
|
Packaging for Perrigo’s Opill, the first OTC birth control pill to be sold in US, features bright teal, saturated pink and yellow, plus a rounded font reminiscent of Gotham; design is intended to set product apart from prescription contraceptive pills
Published:
July 31, 2023
by STAT News
|
Perrigo recalls certain lots of Gerber Good Start SoothePro Powdered Infant Formula in the US because of potential cronobacter sakazakii contamination
Published:
May 15, 2023
by Food Safety News
|
FDA panel backs OTC sales of Perrigo's Opill contraceptive pill; ruling comes despite criticisms from some FDA scientists who voiced concerns about how Perrigo studied the drug
Published:
May 11, 2023
by Associated Press
|
Ask us about our Health Care Sector market view